Euronext announces March 2026 quarterly review results of the MIB ESG®

Back

Milan – 13 March 2026 - Euronext today announced the results of the quarterly review for the MIB ESG® index, which will be implemented after markets close on Friday, 20 March 2026 and will be effective from Monday, 23 March 2026.

Results of the Quarterly Review

MIB ESG®

Inclusion of: Exclusion of: 
FINCANTIERI PIRELLI & C

Euronext retains the right to change the published selection, for instance in the case of a removal due to a takeover, until the publication of the final data after close of Wednesday, 18 March 2026.

All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.

Review MIB ESG®  Family

The MIB ESG® index is reviewed quarterly (March, June, September, December). Next review will be announced on 12 June 2026.

 

CONTACTS  

ANALYSTS & INVESTORS – ir@euronext.com 
Investor Relations Judith Stein  +33 6 15 23 91 97
MEDIA – mediateam@euronext.com 
Europe    Andrea Monzani  +33 1 7048 24 45
Sandra Machado +351 917 776 897
Belgium  Marianne Aalders  +32 26 20 15 01 
France, Corporate  Flavio Bornancin-Tomasella +33 1 70 48 24 45 
Greece Ioulia Zafolia +30 694 570 1070
Ireland Catalina Augspach +39 02 72 42 62 13 
Italy Ester Russom  +39 02 72 42 67 56 
The Netherlands  Marianne Aalders  +31 20 721 41 33 
Norway Cathrine Lorvik Segerlund +47 41 69 59 10 
Portugal Sandra Machado  +351 91 777 68 97
     
Download the press release

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal. In November 2025, Euronext acquired a majority stake in the Athens Stock Exchange (ATHEX), reinforcing its pan-European footprint and further extending its fully integrated market infrastructure with the addition of an exchange, a CSD and a clearing house.

As of February 2026, Euronext’s regulated exchanges in Belgium, France, Greece, Ireland, Italy, the Netherlands, Norway and Portugal host over 1,800 listed issuers with €7 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 29% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.

For the latest news and resources, please visit the Media Centre. 
Follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2026, Euronext N.V. - All rights reserved.